404
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Acceleration of pelvic tissue generation by overexpression of basic fibroblast growth factor in stem cells

ORCID Icon, , &
Pages 256-268 | Received 25 Nov 2020, Accepted 20 Feb 2021, Published online: 19 Apr 2021
 

ABSTRACT

Background

Pelvic organ prolapse (POP) is a common debilitating condition affecting approximately 30–40% of women. The FDA issued a warning about polypropylene mesh used for pelvic floor repair due to erosion, exposure and other complications and banned it in 2019. The application of stem cell therapy and growth factors has strongly promoted the development of pelvic tissue engineering.

Purpose

we intend to address the issues of direct application of growth factors, the side effects of long-term exogenous treatment, and the directional differentiation of stem cells. Methods: we evaluated the paracrine effects and directional differentiation of adipose mesenchymal stem cells through stable overexpression of basic fibroblast growth factor (bFGF).

Results

we found that the modified stem cells could continuously and stably release bFGF in the initial stage and could spontaneously differentiate into fibroblasts with a high differentiation efficiency in the later stage.

Conclusion

following ADSCs are designed to continuously release controllable levels of growth factors during the control period of repair, taking advantage of the paracrine function of stem cells to accelerate cell growth and extracellular matrix (ECM) reconstruction during the early stage of stem cell implantation, and then stem cells are differentiated into target tissues-fibroblasts to accelerate the reconstruction of pelvic floor tissues, this study demonstrated the strong therapeutic potential of this approach for pelvic tissue engineering.

Abbreviations

POP: Pelvic organ prolapse; ADSCs: Adipose-derived stem cells; bFGF: Basic fibroblast growth factor; BMSCs: Bone marrow-derived mesenchymal stem cells; HUVECs: Human umbilical vein endothelial cells; EMSCs: Endometrial mesenchymal stem cells; VEGF: Vascular endothelial growth factor; PDGF: Platelet-derived growth factor ECM: Extracellular matrix; IGF: Insulin-like growth factor; HGF: Hepatocyte growth factor; EGF: Epidermal growth factor; BMP-2: Bone morphogenetic protein 2; FBR: Foreign body reaction.

Acknowledgments

We have a registered preprint online and the link is https://www.researchsquare.com/article/rs-70178/v1

Authors’ contributions

All authors contributed to the experimental design. WXT wrote the manuscript. WXT and JYY acquired, analysed, and interpreted the data. JYY instruct the experiments technology. SXL and WJL supervised the study, interpreted the data, and revised the manuscript. All authors approved the final version of the manuscript.

Data availability statement

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

Disclosure statement

The authors declare that they have no competing interests.

Ethics approval and consent to participate

Not applicable

Additional information

Funding

This work was funded by National key technology research and development program of China (2018YFC2002204, 2019YFC1005200, 2019YFC1005201); the Natural Science Foundation of China (81901461).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.